Cargando…

Autoantibodies other than Anti-desmogleins in Pemphigus Vulgaris Patients

BACKGROUND: Pemphigus vulgaris (PV) is an immunoglobulin G-mediated autoimmune bullous skin disease. Nonorgan-specific antibodies were detected in Tunisian and Brazilian pemphigus patients with different prevalence. MATERIALS AND METHODS: Fifty PV patients and fifty controls were screened for antinu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saleh, Marwah Adly, Salem, Hedayat, El Azizy, Hoda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286753/ https://www.ncbi.nlm.nih.gov/pubmed/28216725 http://dx.doi.org/10.4103/0019-5154.198032

Ejemplares similares

Pathogenic activity of circulating anti-desmoglein-3 autoantibodies isolated from pemphigus vulgaris patients
por: Narbutt, Joanna, et al.
Publicado: (2012)

Evaluation of desmoglein 1 and 3 autoantibodies in pemphigus vulgaris: correlation with disease severity
por: Delavarian, Zahra, et al.
Publicado: (2020)

Long-lasting Localized Pemphigus Vulgaris without Detectable Serum Autoantibodies Against Desmoglein 3 and Desmoglein 1
por: Yoshifuku, Asuka, et al.
Publicado: (2016)

Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris
por: Amber, Kyle T., et al.
Publicado: (2018)

Autoantibodies against desmoglein 2 are not pathogenic in pemphigus()
por: Miguel, Marcela Calixto Brandão, et al.
Publicado: (2022)

A New Solid-Phase Immunosorbent for Selective Binding of Desmoglein 3 Autoantibodies in Patients with Pemphigus Vulgaris
por: Abramova, T. V., et al.
Publicado: (2020)

Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris
por: Schlögl, Elisabeth, et al.
Publicado: (2018)

Identification of a Novel Non-desmoglein Autoantigen in Pemphigus Vulgaris
por: Di Lullo, Giulia, et al.
Publicado: (2019)

Evaluation of anti-desmoglein-1 and anti-desmoglein-3 autoantibody titers in pemphigus patients at the time of the initial diagnosis and after clinical remission
por: Russo, Irene, et al.
Publicado: (2017)

Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris
por: BOCH, Katharina, et al.
Publicado: (2022)

Proteomic definition of a desmoglein linear determinant common to Pemphigus vulgaris and Pemphigus foliaceous
por: Lucchese, Alberta, et al.
Publicado: (2006)

Autoantibodies against Desmoglein 1 and 3 in South Tunisian pemphigus
por: Jerbi, Ameni, et al.
Publicado: (2021)

HLA class II antigens in Croatian patients with pemphigus vulgaris and their correlation with anti-desmoglein antibodies
por: Lakoš Jukić, Ines, et al.
Publicado: (2023)

Do serum prolactin levels correlate with antibodies against desmoglein in pemphigus vulgaris?
por: Iraji, Fariba, et al.
Publicado: (2016)

Improving Treatment Outcome of Pemphigus Vulgaris on Vietnamese Patients by Using Desmoglein Elisa Test
por: Van, Anh Tran Thi, et al.
Publicado: (2019)

Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes
Publicado: (1993)

An adult passive transfer mouse model to study desmoglein 3 signaling in pemphigus vulgaris
por: Schulze, Katja, et al.
Publicado: (2011)

Desmogleins 1, 3, and E-cadherin immunohistochemical expression within mucocutaneous pemphigus vulgaris
por: Alshami, Muhanad Lebnan, et al.
Publicado: (2022)

Pemphigus Foliaceus Autoantibodies Induce Redistribution Primarily of Extradesmosomal Desmoglein 1 in the Cell Membrane
por: Hiermaier, Matthias, et al.
Publicado: (2022)

Detection of Autoantibodies against Recombinant Desmoglein 1 and 3 Molecules in Patients with Pemphigus vulgaris: Correlation with Disease Extent at the Time of Diagnosis and during Follow-Up
por: Belloni-Fortina, Anna, et al.
Publicado: (2009)

Targeted Disruption of the Pemphigus Vulgaris Antigen (Desmoglein 3) Gene in Mice Causes Loss of Keratinocyte Cell Adhesion with a Phenotype Similar to Pemphigus Vulgaris
por: Koch, Peter J., et al.
Publicado: (1997)

Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris
por: Lo, Agnes S., et al.
Publicado: (2016)

Pemphigus Vulgaris Autoantibody Profiling by Proteomic Technique
por: Kalantari-Dehaghi, Mina, et al.
Publicado: (2013)

Mitochondrial Autoantibodies and the Role of Apoptosis in Pemphigus Vulgaris
por: Hutchison, Dana M., et al.
Publicado: (2022)

Anti-Thyroid Peroxidase Reactivity Is Heightened in Pemphigus Vulgaris and Is Driven by Human Leukocyte Antigen Status and the Absence of Desmoglein Reactivity
por: Seiffert-Sinha, Kristina, et al.
Publicado: (2018)

Generation of an anti-desmoglein 3 antibody without pathogenic activity of pemphigus vulgaris for therapeutic application to squamous cell carcinoma
por: Funahashi, Shin-Ichi, et al.
Publicado: (2018)

Acantholysis may precede elevation of circulating anti‐desmoglein 3 antibody levels in pemphigus vulgaris presenting with desquamative gingivitis
por: Endo, Hiroyasu, et al.
Publicado: (2019)

Selective Elevation of Antibodies to Desmoglein 1 during the Transition from Mucocutaneous to Cutaneous Type Pemphigus Vulgaris
por: Matsuda-Hirose, Haruna, et al.
Publicado: (2013)

Plakophilins, desmogleins, and pemphigus: the tail wagging the dog
por: Ellebrecht, Christoph T., et al.
Publicado: (2014)

Desmoglein compensation hypothesis fidelity assessment in Pemphigus
por: Sielski, Lauren, et al.
Publicado: (2022)

Autoantibody Signaling in Pemphigus Vulgaris: Development of an Integrated Model
por: Sajda, Thomas, et al.
Publicado: (2018)

A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants
por: Lotti, Roberta, et al.
Publicado: (2023)

Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab
por: Bhatia, Sravya M., et al.
Publicado: (2020)

Salivary Desmoglein Enzyme-Linked Immunosorbent Assay for Diagnosis of Pemphigus Vulgaris: A Noninvasive Alternative Test to Serum Assessment
por: Mortazavi, Hossein, et al.
Publicado: (2015)

Loss of flotillin expression results in weakened desmosomal adhesion and Pemphigus vulgaris-like localisation of desmoglein-3 in human keratinocytes
por: Völlner, Frauke, et al.
Publicado: (2016)

Oxidative stress in patients with endemic pemphigus foliaceus and healthy subjects with anti-desmoglein 1 antibodies
por: Gutierrez, Ericson Leonardo, et al.
Publicado: (2018)

The Evolving Story of Autoantibodies in Pemphigus Vulgaris: Development of the “Super Compensation Hypothesis”
por: Sinha, Animesh A., et al.
Publicado: (2018)

Estimated cut-off values for pemphigus severity classification according to pemphigus disease area index (PDAI), autoimmune bullous skin disorder intensity score (ABSIS), and anti-desmoglein 1 autoantibodies
por: Mohebi, Farnam, et al.
Publicado: (2020)

FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus
por: Maho-Vaillant, Maud, et al.
Publicado: (2022)

Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice
por: Hofrichter, Maxi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dai288a996dfm79c95upa6j2re